antitussive

(redirected from Antitussives)
Also found in: Dictionary, Thesaurus, Medical.
Related to Antitussives: Expectorants

antitussive

[¦an·tē¦təs·iv]
(pharmacology)
An agent, such as benylin expectorants, that relieves coughing.
Mentioned in ?
References in periodicals archive ?
The study found that when children with acute cough were treated with either antitussive medication or antibiotics, antibiotics alone showed a lower percentage of cough resolution.
On the contrary, children treated with antibiotics only had a lower percentage of cough resolution than children treated with antitussive only.
Of particular concern to the agency are unapproved hydrocodone-containing cough suppressants that carry labels with dosing instructions for children as young as age 2 years, because no antitussive containing hydrocodone has been established as safe and effective for children younger than age 6 years.
FDA officials were not concerned about a shortage of cough suppressants following this action because there are many other antitussive products available as well as grace periods that allow other manufacturers time to increase production if necessary.
A recent randomized, placebo-controlled trial has shown that codeine, a common antitussive agent, was not effective in the management of cough in COPD patients (Smith et al.
There are a couple of studies that suggest the mechanisms of bakumondoto to serve as an antitussive agent.
Concomitant medication for the other patients was predominantly antitussive agents and expectorants (26.
Previous treatment with other therapeutic agents such as antitussive agents and antibiotics, but also concomitant medication with an effect on the respiratory tract, was more likely to have a negative effect on the therapeutic success (score reduction: 4.
Food and Drug Administration (FDA) for an extended-release antitussive product (CRTX 067) that, if approved, would compete directly in the large prescription antitussive market.
This antitussive product is an important part of our overall corporate strategy to compete in the prescription Cough and Cold Preparations market, which represents over 40 million prescriptions annually.
Celltech also manufactures Tussionex(R) (hydrocodone polistirex/ chlorpheniramine polistirex) Extended-Release Suspension CIII, the number one prescribed hydrocodone antitussive, and Delsym(R) Extended-Release Suspension, an over-the-counter (OTC) dextromethorphan antitussive that provides 12-hour cough relief.
List of Antitussive Products (Containing Hydrocodone)